Literature DB >> 27999752

Functional impairment of infiltrating T cells in human colorectal cancer.

Edward S Taylor1, John L McCall2, Adam Girardin1, Fran M Munro2, Michael A Black3, Roslyn A Kemp1.   

Abstract

T cells play a crucial role in preventing the growth and spread of colorectal cancer (CRC). However, immunotherapies against CRC have only shown limited success, which may be due to lack of understanding about the effect of the local tumor microenvironment (TME) on T cell function. The goal of this study was to determine whether T cells in tumor tissue were functionally impaired compared to T cells in non-tumor bowel (NTB) tissue from the same patients. We showed that T cell populations are affected differently by the TME. In the tumor, T cells produced more IL-17 and less IL-2 per cell than their counterparts from NTB tissue. T cells from tumor tissue also had impaired proliferative ability compared to T cells in NTB tissue. This impairment was not related to the frequency of IL-2 producing T cells or regulatory T cells, but T cells from the TME had a higher co-expression of inhibitory receptors than T cells from NTB. Overall, our data indicate that T cells in tumor tissue are functionally altered by the CRC TME, which is likely due to cell intrinsic factors. The TME is therefore an important consideration in predicting the effect of immune modulatory therapies.

Entities:  

Keywords:  Colorectal cancer; IL-2; T cells; exhaustion; proliferation

Year:  2016        PMID: 27999752      PMCID: PMC5139627          DOI: 10.1080/2162402X.2016.1234573

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  42 in total

Review 1.  Anatomical basis of tolerance and immunity to intestinal antigens.

Authors:  Allan McI Mowat
Journal:  Nat Rev Immunol       Date:  2003-04       Impact factor: 53.106

2.  Effector memory T cells, early metastasis, and survival in colorectal cancer.

Authors:  Franck Pagès; Anne Berger; Matthieu Camus; Fatima Sanchez-Cabo; Anne Costes; Robert Molidor; Bernhard Mlecnik; Amos Kirilovsky; Malin Nilsson; Diane Damotte; Tchao Meatchi; Patrick Bruneval; Paul-Henri Cugnenc; Zlatko Trajanoski; Wolf-Herman Fridman; Jérôme Galon
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

3.  The frequency of Th17 and Th22 cells in patients with colorectal cancer at pre-operation and post-operation.

Authors:  Limian Ling; Pingwei Zhao; Guoqiang Yan; Mingxiao Chen; Ting Zhang; Lei Wang; Yanfang Jiang
Journal:  Immunol Invest       Date:  2014-07-15       Impact factor: 3.657

4.  HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker.

Authors:  Giuseppe Sconocchia; Serenella Eppenberger-Castori; Inti Zlobec; Eva Karamitopoulou; Roberto Arriga; Andrea Coppola; Sara Caratelli; Giulio Cesare Spagnoli; Davide Lauro; Alessandro Lugli; Junyi Han; Giandomenica Iezzi; Cristina Ferrone; Amedeo Ferlosio; Luigi Tornillo; Raoul Droeser; Piero Rossi; Antonio Attanasio; Soldano Ferrone; Luigi Terracciano
Journal:  Neoplasia       Date:  2014-01       Impact factor: 5.715

Review 5.  Clinical blockade of PD1 and LAG3--potential mechanisms of action.

Authors:  Linh T Nguyen; Pamela S Ohashi
Journal:  Nat Rev Immunol       Date:  2015-01       Impact factor: 53.106

6.  PD-L1 expression in colorectal cancer is associated with microsatellite instability, BRAF mutation, medullary morphology and cytotoxic tumor-infiltrating lymphocytes.

Authors:  Matthew W Rosenbaum; Jacob R Bledsoe; Vicente Morales-Oyarvide; Tiffany G Huynh; Mari Mino-Kenudson
Journal:  Mod Pathol       Date:  2016-05-20       Impact factor: 7.842

7.  Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells.

Authors:  Matthew A Williams; Aaron J Tyznik; Michael J Bevan
Journal:  Nature       Date:  2006-06-15       Impact factor: 49.962

8.  Single cell analysis reveals regulated hierarchical T cell antigen receptor signaling thresholds and intraclonal heterogeneity for individual cytokine responses of CD4+ T cells.

Authors:  Y Itoh; R N Germain
Journal:  J Exp Med       Date:  1997-08-29       Impact factor: 14.307

Review 9.  The role of interleukin 17 in tumour proliferation, angiogenesis, and metastasis.

Authors:  Bob Yang; Heechan Kang; Anthony Fung; Hailin Zhao; Tianlong Wang; Daqing Ma
Journal:  Mediators Inflamm       Date:  2014-07-07       Impact factor: 4.711

10.  Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer.

Authors:  F Amicarella; M G Muraro; C Hirt; E Cremonesi; E Padovan; V Mele; V Governa; J Han; X Huber; R A Droeser; M Zuber; M Adamina; M Bolli; R Rosso; A Lugli; I Zlobec; L Terracciano; L Tornillo; P Zajac; S Eppenberger-Castori; F Trapani; D Oertli; G Iezzi
Journal:  Gut       Date:  2015-12-30       Impact factor: 23.059

View more
  9 in total

Review 1.  Regulation of T cell immunity by cellular metabolism.

Authors:  Zhilin Hu; Qiang Zou; Bing Su
Journal:  Front Med       Date:  2018-08-16       Impact factor: 4.592

2.  DNA methylation-based signature of CD8+ tumor-infiltrating lymphocytes enables evaluation of immune response and prognosis in colorectal cancer.

Authors:  Qi Zou; Xiaolin Wang; Donglin Ren; Huichuan Yu; Yanxin Luo; Bang Hu; Guannan Tang; Yu Zhang; Meijin Huang; Rish K Pai; Daniel D Buchanan; Aung Ko Win; Polly A Newcomb; William M Grady
Journal:  J Immunother Cancer       Date:  2021-09       Impact factor: 12.469

Review 3.  Current and Prospective Methods for Assessing Anti-Tumor Immunity in Colorectal Cancer.

Authors:  Yulia I Nussbaum; Yariswamy Manjunath; Kanve N Suvilesh; Wesley C Warren; Chi-Ren Shyu; Jussuf T Kaifi; Matthew A Ciorba; Jonathan B Mitchem
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

Review 4.  Impact of Metabolism on T-Cell Differentiation and Function and Cross Talk with Tumor Microenvironment.

Authors:  Soumaya Kouidhi; Amel Benammar Elgaaied; Salem Chouaib
Journal:  Front Immunol       Date:  2017-03-13       Impact factor: 7.561

5.  The Different Functional Distribution of "Not Effector" T Cells (Treg/Tnull) in Colorectal Cancer.

Authors:  Elena Niccolai; Federica Ricci; Edda Russo; Giulia Nannini; Giacomo Emmi; Antonio Taddei; Maria Novella Ringressi; Filippo Melli; Manouela Miloeva; Fabio Cianchi; Paolo Bechi; Domenico Prisco; Amedeo Amedei
Journal:  Front Immunol       Date:  2017-12-22       Impact factor: 7.561

Review 6.  Regulatory T-cell heterogeneity and the cancer immune response.

Authors:  Kirsten A Ward-Hartstonge; Roslyn A Kemp
Journal:  Clin Transl Immunology       Date:  2017-09-15

7.  14-3-3ζ delivered by hepatocellular carcinoma-derived exosomes impaired anti-tumor function of tumor-infiltrating T lymphocytes.

Authors:  Xiaochen Wang; Haiyuan Shen; Guangyan Zhangyuan; Ruyi Huang; Wenjie Zhang; Qifeng He; Kangpeng Jin; Han Zhuo; Zechuan Zhang; Jincheng Wang; Beicheng Sun; Xiaojie Lu
Journal:  Cell Death Dis       Date:  2018-02-07       Impact factor: 8.469

Review 8.  Multiparametric analysis of colorectal cancer immune responses.

Authors:  Julia Kh Leman; Sarah K Sandford; Janet L Rhodes; Roslyn A Kemp
Journal:  World J Gastroenterol       Date:  2018-07-21       Impact factor: 5.742

9.  Tumor Infiltrating Lymphocytes Target HLA-I Phosphopeptides Derived From Cancer Signaling in Colorectal Cancer.

Authors:  Sarah A Penny; Jennifer G Abelin; Stacy A Malaker; Paisley T Myers; Abu Z Saeed; Lora G Steadman; Dina L Bai; Stephen T Ward; Jeffrey Shabanowitz; Donald F Hunt; Mark Cobbold
Journal:  Front Immunol       Date:  2021-08-24       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.